Stress responses from the endoplasmic reticulum in cancer

Frontiers in Oncology

Volumn 5, Issue APR, 2015, Pages

  Kato, Hironori ^a   Nishitoh, Hideki ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Cancer; Endoplasmic reticulum; ER stress; Mitochondria associated ER membrane; Unfolded protein response

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; CRYOPYRIN; GLYCEROPHOSPHOLIPID; INOSITOL REQUIRING ENZYME 1 ALPHA; MITOFUSIN 1; MITOFUSIN 2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN IRE1; RIBONUCLEASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SPHINGOLIPID; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

APOPTOSIS; CALCIUM SIGNALING; CANCER SURVIVAL; CELL PROLIFERATION; DNA DAMAGE; ENDOPLASMIC RETICULUM MEMBRANE; ENDOPLASMIC RETICULUM STRESS; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLAMMATION; INNATE IMMUNITY; NEOPLASM; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR MICROENVIRONMENT; UNFOLDED PROTEIN RESPONSE;

EID: 84934755624     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00093     Document Type: Review

References (194)

1. Tehlivets O, Scheuringer K, Kohlwein SD. Fatty acid synthesis and elongation in yeast. Biochim Biophys Acta (2007) 1771:255-70. doi: 10.1016/j.bbalip.2006.07.004
2. Kleizen B, Braakman I. Protein folding and quality control in the endoplasmic reticulum. Curr Opin Cell Biol (2004) 16:343-9. doi:10.1016/j.ceb.2004.08.003
3. Vance JE, Vance DE. Phospholipid biosynthesis in mammalian cells. Biochem Cell Biol (2004) 82:113-28. doi:10.1139/o03-073
4. Brostrom MA, Brostrom CO. Calcium dynamics and endoplasmic reticular function in the regulation of protein synthesis: implications for cell growth and adaptability. Cell Calcium (2003) 34:345-63. doi:10.1016/S0143-4160(03)00127-1
5. Berridge MJ. The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium (2002) 32:235-49. doi:10.1016/S0143416002001823
6. Gagnon E, Duclos S, Rondeau C, Chevet E, Cameron PH, Steele-Mortimer O, et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell (2002) 110:119-31. doi:10.1016/S0092-8674(02)00797-3
7. Wang S, Kaufman RJ. The impact of the unfolded protein response on human disease. J Cell Biol (2012) 197:857-67. doi:10.1083/jcb.201110131
8. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol (2007) 8:519-29. doi:10.1038/nrm2199
9. Volmer R, Van Der Ploeg K, Ron D. Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains. Proc Natl Acad Sci U S A (2013) 110:4628-33. doi:10.1073/pnas.1217611110
10. Kitai Y, Ariyama H, Kono N, Oikawa D, Iwawaki T, Arai H. Membrane lipid saturation activates IRE1alpha without inducing clustering. Genes Cells (2013) 18:798-809. doi:10.1111/gtc.12074
11. Mekahli D, Bultynck G, Parys JB, De Smedt H, Missiaen L. Endoplasmic-reticulum calcium depletion and disease. Cold Spring Harb Perspect Biol (2011) 3:a004317. doi:10.1101/cshperspect.a004317
12. Ariyama H, Kono N, Matsuda S, Inoue T, Arai H. Decrease in membrane phospholipid unsaturation induces unfolded protein response. J Biol Chem (2010) 285:22027-35. doi:10.1074/jbc.M110.126870
13. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell (2010) 140:900-17. doi:10.1016/j.cell.2010.02.034
14. Thastrup O, Cullen PJ, Drobak BK, Hanley MR, Dawson AP. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci U S A (1990) 87:2466-70. doi:10.1073/pnas.87.7.2466
15. Rutkowski DT, Kaufman RJ. A trip to the ER: coping with stress. Trends Cell Biol (2004) 14:20-8. doi:10.1016/j.tcb.2003.11.001
16. Lee AS. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res (2007) 67:3496-9. doi:10.1158/0008-5472.CAN-07-0325
17. Moenner M, Pluquet O, Bouchecareilh M, Chevet E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res (2007) 67:10631-4. doi:10.1158/0008-5472.CAN-07-1705
18. Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee AH, Yoshida H, et al. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res (2004) 64:5943-7. doi:10.1158/0008-5472.CAN-04-1606
19. Csordas G, Renken C, Varnai P, Walter L, Weaver D, Buttle KF, et al. Structural and functional features and significance of the physical linkage between ER and mitochondria. J Cell Biol (2006) 174:915-21. doi:10.1083/jcb.200604016
20. Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz LM, et al. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science (1998) 280:1763-6. doi:10.1126/science.280.5370.1763
21. De Brito OM, Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature (2008) 456:605-10. doi:10.1038/nature07534
22. Szabadkai G, Bianchi K, Varnai P, De Stefani D, Wieckowski MR, Cavagna D, et al. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J Cell Biol (2006) 175:901-11. doi:10.1083/jcb.200608073
23. Iwasawa R, Mahul-Mellier AL, Datler C, Pazarentzos E, Grimm S. Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction. EMBO J (2011) 30:556-68. doi:10.1038/emboj.2010.346
24. De Vos KJ, Morotz GM, Stoica R, Tudor EL, Lau KF, Ackerley S, et al. VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum Mol Genet (2012) 21:1299-311. doi:10.1093/hmg/ddr559
25. Rusinol AE, Cui Z, Chen MH, Vance JE. A unique mitochondria-associated membrane fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins including nascent lipoproteins. J Biol Chem (1994) 269:27494-502.
26. Vance JE. Newly made phosphatidylserine and phosphatidylethanolamine are preferentially translocated between rat liver mitochondria and endoplasmic reticulum. J Biol Chem (1991) 266:89-97.
27. Vance JE. Phospholipid synthesis in a membrane fraction associated with mitochondria. J Biol Chem (1990) 265:7248-56.
28. Filippin L, Magalhaes PJ, Di Benedetto G, Colella M, Pozzan T. Stable interactions between mitochondria and endoplasmic reticulum allow rapid accumulation of calcium in a subpopulation of mitochondria. J Biol Chem (2003) 278:39224-34. doi:10.1074/jbc.M302301200
29. Rizzuto R, Brini M, Murgia M, Pozzan T. Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science (1993) 262:744-7. doi:10.1126/science.8235595
30. Cardenas C, Miller RA, Smith I, Bui T, Molgo J, Muller M, et al. Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell (2010) 142:270-83. doi:10.1016/j.cell.2010.06.007
31. Sano R, Annunziata I, Patterson A, Moshiach S, Gomero E, Opferman J, et al. GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca(2+)-dependent mitochondrial apoptosis. Mol Cell (2009) 36:500-11. doi:10.1016/j.molcel.2009.10.021
32. Browman DT, Resek ME, Zajchowski LD, Robbins SM. Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER. J Cell Sci (2006) 119:3149-60. doi:10.1242/jcs.03060
33. Hayashi T, Su TP. Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J Pharmacol Exp Ther (2003) 306:718-25. doi:10.1124/jpet.103.051284
34. Lewin TM, Kim JH, Granger DA, Vance JE, Coleman RA. Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J Biol Chem (2001) 276:24674-9. doi:10.1074/jbc.M102036200
35. Stone SJ, Vance JE. Phosphatidylserine synthase-1 and -2 are localized to mitochondria-associated membranes. J Biol Chem (2000) 275:34534-40. doi:10.1074/jbc.M002865200
36. Santos CR, Schulze A. Lipid metabolism in cancer. FEBS J (2012) 279:2610-23. doi:10.1111/j.1742-4658.2012.08644.x
37. Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol (2008) 9:162-76. doi:10.1038/nrm2335
38. Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer (2004) 4:604-16. doi:10.1038/nrc1411
39. Van Vliet AR, Verfaillie T, Agostinis P. New functions of mitochondria associated membranes in cellular signaling. Biochim Biophys Acta (2014) 1843:2253-62. doi:10.1016/j.bbamcr.2014.03.009
40. Raturi A, Simmen T. Where the endoplasmic reticulum and the mitochondrion tie the knot: the mitochondria-associated membrane (MAM). Biochim Biophys Acta (2013) 1833:213-24. doi:10.1016/j.bbamcr.2012.04.013
41. Simmen T, Lynes EM, Gesson K, Thomas G. Oxidative protein folding in the endoplasmic reticulum: tight links to the mitochondria-associated membrane (MAM). Biochim Biophys Acta (2010) 1798:1465-73. doi:10.1016/j.bbamem.2010.04.009
42. Wang WA, Groenendyk J, Michalak M. Endoplasmic reticulum stress associated responses in cancer. Biochim Biophys Acta (2014) 1843:2143-9. doi:10.1016/j.bbamcr.2014.01.012
43. Clarke HJ, Chambers JE, Liniker E, Marciniak SJ. Endoplasmic reticulum stress in malignancy. Cancer Cell (2014) 25:563-73. doi:10.1016/j.ccr.2014.03.015
44. Park HR, Tomida A, Sato S, Tsukumo Y, Yun J, Yamori T, et al. Effect on tumor cells of blocking survival response to glucose deprivation. J Natl Cancer Inst (2004) 96:1300-10. doi:10.1093/jnci/djh243
45. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res (1998) 58:1408-16.
46. Papp B, Brouland JP, Arbabian A, Gelebart P, Kovacs T, Bobe R, et al. Endoplasmic reticulum calcium pumps and cancer cell differentiation. Biomolecules (2012) 2:165-86. doi:10.3390/biom2010165
47. Prevarskaya N, Skryma R, Shuba Y. Calcium in tumour metastasis: new roles for known actors. Nat Rev Cancer (2011) 11:609-18. doi:10.1038/nrc3105
48. Roderick HL, Cook SJ. Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat Rev Cancer (2008) 8:361-75. doi:10.1038/nrc2374
49. Bravo R, Parra V, Gatica D, Rodriguez AE, Torrealba N, Paredes F, et al. Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. Int Rev Cell Mol Biol (2013) 301:215-90. doi:10.1016/B978-0-12-407704-1.00005-1
50. Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell (2000) 6:1099-108. doi:10.1016/S1097-2765(00)00108-8
51. Trinh MA, Klann E. Translational control by eIF2alpha kinases in long-lasting synaptic plasticity and long-term memory. Neurobiol Learn Mem (2013) 105:93-9. doi:10.1016/j.nlm.2013.04.013
52. Wek RC, Cavener DR. Translational control and the unfolded protein response. Antioxid Redox Signal (2007) 9:2357-71. doi:10.1089/ars.2007.1764
53. Wek RC, Jiang HY, Anthony TG. Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans (2006) 34:7-11. doi:10.1042/BST0340007
54. Jaramillo MC, Zhang DD. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev (2013) 27:2179-91. doi:10.1101/gad.225680.113
55. Cullinan SB, Diehl JA. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J Biol Chem (2004) 279:20108-17. doi:10.1074/jbc.M314219200
56. Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, Diehl JA. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol (2003) 23:7198-209. doi:10.1128/MCB.23.20.7198-7209.2003
57. Lu PD, Jousse C, Marciniak SJ, Zhang Y, Novoa I, Scheuner D, et al. Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2. EMBO J (2004) 23:169-79. doi:10.1038/sj.emboj.7600030
58. Han J, Back SH, Hur J, Lin YH, Gildersleeve R, Shan J, et al. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat Cell Biol (2013) 15:481-90. doi:10.1038/ncb2738
59. Song B, Scheuner D, Ron D, Pennathur S, Kaufman RJ. Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J Clin Invest (2008) 118:3378-89. doi:10.1172/JCI34587
60. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev (2004) 18:3066-77. doi:10.1101/gad.1250704
61. Kutomi G, Tamura Y, Tanaka T, Kajiwara T, Kukita K, Ohmura T, et al. Human endoplasmic reticulum oxidoreductin 1-alpha is a novel predictor for poor prognosis of breast cancer. Cancer Sci (2013) 104:1091-6. doi:10.1111/cas.12177
62. Bobrovnikova-Marjon E, Grigoriadou C, Pytel D, Zhang F, Ye J, Koumenis C, et al. PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene (2010) 29:3881-95. doi:10.1038/onc.2010.153
63. Wang Y, Alam GN, Ning Y, Visioli F, Dong Z, Nor JE, et al. The unfolded protein response induces the angiogenic switch in human tumor cells through the PERK/ATF4 pathway. Cancer Res (2012) 72:5396-406. doi:10.1158/0008-5472.CAN-12-0474
64. Ye J, Kumanova M, Hart LS, Sloane K, Zhang H, De Panis DN, et al. The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J (2010) 29:2082-96. doi:10.1038/emboj.2010.81
65. Atkins C, Liu Q, Minthorn E, Zhang SY, Figueroa DJ, Moss K, et al. Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res (2013) 73:1993-2002. doi:10.1158/0008-5472.CAN-12-3109
66. Drexler HC. Synergistic apoptosis induction in leukemic cells by the phosphatase inhibitor salubrinal and proteasome inhibitors. PLoS One (2009) 4:e4161. doi:10.1371/journal.pone.0004161
67. Hollien J, Lin JH, Li H, Stevens N, Walter P, Weissman JS. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J Cell Biol (2009) 186:323-31. doi:10.1083/jcb.200903014
68. Hetz C, Glimcher LH. Fine-tuning of the unfolded protein response: Assembling the IRE1alpha interactome. Mol Cell (2009) 35:551-61. doi:10.1016/j.molcel.2009.08.021
69. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (1992) 359:845-8. doi:10.1038/359845a0
70. Chen X, Iliopoulos D, Zhang Q, Tang Q, Greenblatt MB, Hatziapostolou M, et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway. Nature (2014) 508:103-7. doi:10.1038/nature13119
71. Dejeans N, Pluquet O, Lhomond S, Grise F, Bouchecareilh M, Juin A, et al. Autocrine control of glioma cells adhesion and migration through IRE1alpha-mediated cleavage of SPARC mRNA. J Cell Sci (2012) 125:4278-87. doi:10.1242/jcs.099291
72. Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev (2002) 16:1345-55. doi:10.1101/gad.992302
73. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science (2000) 287:664-6. doi:10.1126/science.287.5453.664
74. Fuest M, Willim K, Macnelly S, Fellner N, Resch GP, Blum HE, et al. The transcription factor c-Jun protects against sustained hepatic endoplasmic reticulum stress thereby promoting hepatocyte survival. Hepatology (2012) 55:408-18. doi:10.1002/hep.24699
75. Zhao P, Xiao X, Kim AS, Leite MF, Xu J, Zhu X, et al. c-Jun inhibits thapsigargin-induced ER stress through up-regulation of DSCR1/Adapt78. Exp Biol Med (Maywood) (2008) 233:1289-300. doi:10.3181/0803-RM-84
76. Yang W, Tiffany-Castiglioni E, Koh HC, Son IH. Paraquat activates the IRE1/ASK1/JNK cascade associated with apoptosis in human neuroblastoma SH-SY5Y cells. Toxicol Lett (2009) 191:203-10. doi:10.1016/j.toxlet.2009.08.024
77. Ding WX, Ni HM, Gao W, Yoshimori T, Stolz DB, Ron D, et al. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol (2007) 171:513-24. doi:10.2353/ajpath.2007.070188
78. Wang L, Perera BG, Hari SB, Bhhatarai B, Backes BJ, Seeliger MA, et al. Divergent allosteric control of the IRE1alpha endoribonuclease using kinase inhibitors. Nat Chem Biol (2012) 8:982-9. doi:10.1038/nchembio.1094
79. Wheeler MC, Rizzi M, Sasik R, Almanza G, Hardiman G, Zanetti M. KDEL-retained antigen in B lymphocytes induces a proinflammatory response: a possible role for endoplasmic reticulum stress in adaptive T cell immunity. J Immunol (2008) 181:256-64. doi:10.4049/jimmunol.181.1.256
80. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell (2000) 103:239-52. doi:10.1016/S0092-8674(00)00116-1
81. Mahadevan NR, Fernandez A, Rodvold JJ, Almanza G, Zanetti M. Prostate cancer cells undergoing ER stress in vitro and in vivo activate transcription of pro-inflammatory cytokines. J Inflamm Res (2010) 3:99-103. doi:10.2147/JIR.S11190
82. Martinon F, Chen X, Lee AH, Glimcher LH. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol (2010) 11:411-8. doi:10.1038/ni.1857
83. Mahadevan NR, Rodvold J, Sepulveda H, Rossi S, Drew AF, Zanetti M. Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells. Proc Natl Acad Sci U S A (2011) 108:6561-6. doi:10.1073/pnas.1008942108
84. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med (2007) 13:54-61. doi:10.1038/nm1523
85. Martins I, Kepp O, Schlemmer F, Adjemian S, Tailler M, Shen S, et al. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene (2011) 30:1147-58. doi:10.1038/onc.2010.500
86. Zhang J, Jiang Y, Jia Z, Li Q, Gong W, Wang L, et al. Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clin Exp Metastasis (2006) 23:401-10. doi:10.1007/s10585-006-9051-9
87. Fu Y, Lee AS. Glucose regulated proteins in cancer progression, drug resistance and immunotherapy. Cancer Biol Ther (2006) 5:741-4. doi:10.4161/cbt.5.7.2970
88. Jamora C, Dennert G, Lee AS. Inhibition of tumor progression by suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME. Proc Natl Acad Sci U S A (1996) 93:7690-4. doi:10.1073/pnas.93.15.7690
89. Coe H, Michalak M. Calcium binding chaperones of the endoplasmic reticulum. Gen Physiol Biophys (2009) 28:F96-103.
90. Guerrero-Hernandez A, Dagnino-Acosta A, Verkhratsky A. An intelligent sarco-endoplasmic reticulum Ca2+ store: release and leak channels have differential access to a concealed Ca2+ pool. Cell Calcium (2010) 48:143-9. doi:10.1016/j.ceca.2010.08.001
91. Taylor CW, Tovey SC. IP(3) receptors: toward understanding their activation. Cold Spring Harb Perspect Biol (2010) 2:a004010. doi:10.1101/cshperspect.a004010
92. Zalk R, Lehnart SE, Marks AR. Modulation of the ryanodine receptor and intracellular calcium. Annu Rev Biochem (2007) 76:367-85. doi:10.1146/annurev.biochem.76.053105.094237
93. Marks AR. Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. J Mol Cell Cardiol (2001) 33:615-24. doi:10.1006/jmcc.2000.1343
94. Clapham DE. Calcium signaling. Cell (2007) 131:1047-58. doi:10.1016/j.cell.2007.11.028
95. Vandecaetsbeek I, Trekels M, De Maeyer M, Ceulemans H, Lescrinier E, Raeymaekers L, et al. Structural basis for the high Ca2+ affinity of the ubiquitous SERCA2b Ca2+ pump. Proc Natl Acad Sci U S A (2009) 106:18533-8. doi:10.1073/pnas.0906797106
96. Brini M, Carafoli E. Calcium pumps in health and disease. Physiol Rev (2009) 89:1341-78. doi:10.1152/physrev.00032.2008
97. Periasamy M, Kalyanasundaram A. SERCA pump isoforms: their role in calcium transport and disease. Muscle Nerve (2007) 35:430-42. doi:10.1002/mus.20745
98. Bhupathy P, Babu GJ, Periasamy M. Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase. J Mol Cell Cardiol (2007) 42:903-11. doi:10.1016/j.yjmcc.2007.03.738
99. Kho C, Lee A, Jeong D, Oh JG, Chaanine AH, Kizana E, et al. SUMO1-dependent modulation of SERCA2a in heart failure. Nature (2011) 477:601-5. doi:10.1038/nature10407
100. Knyushko TV, Sharov VS, Williams TD, Schoneich C, Bigelow DJ. 3-Nitrotyrosine modification of SERCA2a in the aging heart: a distinct signature of the cellular redox environment. Biochemistry (2005) 44:13071-81. doi:10.1021/bi051226n
101. Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schoneich C, et al. S-glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med (2004) 10:1200-7. doi:10.1038/nm1119
102. Korosec B, Glavac D, Rott T, Ravnik-Glavac M. Alterations in the ATP2A2 gene in correlation with colon and lung cancer. Cancer Genet Cytogenet (2006) 171:105-11. doi:10.1016/j.cancergencyto.2006.06.016
103. Endo Y, Uzawa K, Mochida Y, Shiiba M, Bukawa H, Yokoe H, et al. Sarcoendoplasmic reticulum Ca(2+) ATPase type 2 downregulated in human oral squamous cell carcinoma. Int J Cancer (2004) 110:225-31. doi:10.1002/ijc.20118
104. Pacifico F, Ulianich L, De Micheli S, Treglia S, Leonardi A, Vito P, et al. The expression of the sarco/endoplasmic reticulum Ca2+-ATPases in thyroid and its down-regulation following neoplastic transformation. J Mol Endocrinol (2003) 30:399-409. doi:10.1677/jme.0.0300399
105. Gelebart P, Kovacs T, Brouland JP, Van Gorp R, Grossmann J, Rivard N, et al. Expression of endomembrane calcium pumps in colon and gastric cancer cells. Induction of SERCA3 expression during differentiation. J Biol Chem (2002) 277:26310-20. doi:10.1074/jbc.M201747200
106. Brouland JP, Gelebart P, Kovacs T, Enouf J, Grossmann J, Papp B. The loss of sarco/endoplasmic reticulum calcium transport ATPase 3 expression is an early event during the multistep process of colon carcinogenesis. Am J Pathol (2005) 167:233-42. doi:10.1016/S0002-9440(10)62968-9
107. Sorrentino V, Barone V, Rossi D. Intracellular Ca(2+) release channels in evolution. Curr Opin Genet Dev (2000) 10:662-7. doi:10.1016/S0959-437X(00)00139-8
108. Taylor CW, Genazzani AA, Morris SA. Expression of inositol trisphosphate receptors. Cell Calcium (1999) 26:237-51. doi:10.1054/ceca.1999.0090
109. Kiselyov K, Shin DM, Muallem S. Signalling specificity in GPCR-dependent Ca2+ signalling. Cell Signal (2003) 15:243-53. doi:10.1016/S0898-6568(02)00074-8
110. Rhee SG. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem (2001) 70:281-312. doi:10.1146/annurev.biochem.70.1.281
111. Narayanan D, Adebiyi A, Jaggar JH. Inositol trisphosphate receptors in smooth muscle cells. Am J Physiol Heart Circ Physiol (2012) 302:H2190-210. doi:10.1152/ajpheart.01146.2011
112. Patterson RL, Boehning D, Snyder SH. Inositol 1,4,5-trisphosphate receptors as signal integrators. Annu Rev Biochem (2004) 73:437-65. doi:10.1146/annurev.biochem.73.071403.161303
113. Szado T, Vanderheyden V, Parys JB, De Smedt H, Rietdorf K, Kotelevets L, et al. Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis. Proc Natl Acad Sci U S A (2008) 105:2427-32. doi:10.1073/pnas.0711324105
114. Khan MT, Wagner L II, Yule DI, Bhanumathy C, Joseph SK. Akt kinase phosphorylation of inositol 1,4,5-trisphosphate receptors. J Biol Chem (2006) 281:3731-7. doi:10.1074/jbc.M509262200
115. Oakes SA, Scorrano L, Opferman JT, Bassik MC, Nishino M, Pozzan T, et al. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc Natl Acad Sci U S A (2005) 102:105-10. doi:10.1073/pnas.0408352102
116. Azimi I, Roberts-Thomson SJ, Monteith GR. Calcium influx pathways in breast cancer: opportunities for pharmacological intervention. Br J Pharmacol (2014) 171:945-60. doi:10.1111/bph.12486
117. Mound A, Rodat-Despoix L, Bougarn S, Ouadid-Ahidouch H, Matifat F. Molecular interaction and functional coupling between type 3 inositol 1,4,5-trisphosphate receptor and BKCa channel stimulate breast cancer cell proliferation. Eur J Cancer (2013) 49:3738-51. doi:10.1016/j.ejca.2013.07.013
118. Szatkowski C, Parys JB, Ouadid-Ahidouch H, Matifat F. Inositol 1,4,5-trisphosphate-induced Ca2+ signalling is involved in estradiol-induced breast cancer epithelial cell growth. Mol Cancer (2010) 9:156. doi:10.1186/1476-4598-9-156
119. De Mattia F, Gubser C, Van Dommelen MM, Visch HJ, Distelmaier F, Postigo A, et al. Human Golgi antiapoptotic protein modulates intracellular calcium fluxes. Mol Biol Cell (2009) 20:3638-45. doi:10.1091/mbc.E09-05-0385
120. Davis FM, Parsonage MT, Cabot PJ, Parat MO, Thompson EW, Roberts-Thomson SJ, et al. Assessment of gene expression of intracellular calcium channels, pumps and exchangers with epidermal growth factor-induced epithelial-mesenchymal transition in a breast cancer cell line. Cancer Cell Int (2013) 13:76. doi:10.1186/1475-2867-13-76
121. Sakakura C, Hagiwara A, Fukuda K, Shimomura K, Takagi T, Kin S, et al. Possible involvement of inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers. Anticancer Res (2003) 23:3691-7.
122. Pierro C, Cook SJ, Foets TC, Bootman MD, Roderick HL. Oncogenic K-Ras suppresses IP(3)-dependent Ca(2)(+) release through remodelling of the isoform composition of IP(3)Rs and ER luminal Ca(2)(+) levels in colorectal cancer cell lines. J Cell Sci (2014) 127:1607-19. doi:10.1242/jcs.141408
123. Bergner A, Kellner J, Tufman A, Huber RM. Endoplasmic reticulum Ca2+-homeostasis is altered in small and non-small cell lung cancer cell lines. J Exp Clin Cancer Res (2009) 28:25. doi:10.1186/1756-9966-28-25
124. Choe CU, Ehrlich BE. The inositol 1,4,5-trisphosphate receptor (IP3R) and its regulators: sometimes good and sometimes bad teamwork. Sci STKE (2006) 2006:re15. doi:10.1126/stke.3632006re15
125. Baljinnyam E, De Lorenzo MS, Xie LH, Iwatsubo M, Chen S, Goydos JS, et al. Exchange protein directly activated by cyclic AMP increases melanoma cell migration by a Ca2+-dependent mechanism. Cancer Res (2010) 70:5607-17. doi:10.1158/0008-5472.CAN-10-0056
126. Somers G, Devis G, Malaisse WJ. Calcium antagonists and islet function. IX. Is extracellular calcium required for insulin release? Acta Diabetol Lat (1979) 16:9-18. doi:10.1007/BF02590758
127. Rasschaert J, Malaisse WJ. Expression of the calcium-sensing receptor in pancreatic islet B-cells. Biochem Biophys Res Commun (1999) 264:615-8. doi:10.1006/bbrc.1999.1577
128. English AR, Zurek N, Voeltz GK. Peripheral ER structure and function. Curr Opin Cell Biol (2009) 21:596-602. doi:10.1016/j.ceb.2009.04.004
129. Laplante M, Sabatini DM. An emerging role of mTOR in lipid biosynthesis. Curr Biol (2009) 19:R1046-52. doi:10.1016/j.cub.2009.09.058
130. Fagone P, Jackowski S. Membrane phospholipid synthesis and endoplasmic reticulum function. J Lipid Res (2009) 50(Suppl):S311-6. doi:10.1194/jlr.R800049-JLR200
131. Ntambi JM. The regulation of stearoyl-CoA desaturase (SCD). Prog Lipid Res (1995) 34:139-50. doi:10.1016/0163-7827(94)00010-J
132. Van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol (2008) 9:112-24. doi:10.1038/nrm2330
133. Hemmings BA, Restuccia DF. PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol (2012) 4:a011189. doi:10.1101/cshperspect.a011189
134. Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci (2009) 122:3589-94. doi:10.1242/jcs.051011
135. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell (2006) 124:471-84. doi:10.1016/j.cell.2006.01.016
136. Yecies JL, Manning BD. mTOR links oncogenic signaling to tumor cell metabolism. J Mol Med (Berl) (2011) 89:221-8. doi:10.1007/s00109-011-0726-6
137. Howell JJ, Manning BD. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol Metab (2011) 22:94-102. doi:10.1016/j.tem.2010.12.003
138. Maehama T, Taylor GS, Dixon JE. PTEN and myotubularin: novel phosphoinositide phosphatases. Annu Rev Biochem (2001) 70:247-79. doi:10.1146/annurev.biochem.70.1.247
139. Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem (1998) 273:13375-8. doi:10.1074/jbc.273.22.13375
140. Georgescu MM. PTEN tumor suppressor network in PI3K-Akt pathway control. Genes Cancer (2010) 1:1170-7. doi:10.1177/1947601911407325
141. Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets (2008) 8:187-98. doi:10.2174/156800908784293659
142. Rodon J, Dienstmann R, Serra V, Tabernero J. Development of PI3K inhibitors: lessons learned from early clinical trials. Nat Rev Clin Oncol (2013) 10:143-53. doi:10.1038/nrclinonc.2013.10
143. Tornquist K. Sphingosine 1-phosphate and cancer: lessons from thyroid cancer cells. Biomolecules (2013) 3:303-15. doi:10.3390/biom3020303
144. Ryland LK, Fox TE, Liu X, Loughran TP, Kester M. Dysregulation of sphingolipid metabolism in cancer. Cancer Biol Ther (2011) 11:138-49. doi:10.4161/cbt.11.2.14624
145. Modrak DE, Gold DV, Goldenberg DM. Sphingolipid targets in cancer therapy. Mol Cancer Ther (2006) 5:200-8. doi:10.1158/1535-7163.MCT-05-0420
146. Miller AV, Alvarez SE, Spiegel S, Lebman DA. Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor beta-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells. Mol Cell Biol (2008) 28:4142-51. doi:10.1128/MCB.01465-07
147. El-Shewy HM, Johnson KR, Lee MH, Jaffa AA, Obeid LM, Luttrell LM. Insulin-like growth factors mediate heterotrimeric G protein-dependent ERK1/2 activation by transactivating sphingosine 1-phosphate receptors. J Biol Chem (2006) 281:31399-407. doi:10.1074/jbc.M605339200
148. Waters C, Sambi B, Kong KC, Thompson D, Pitson SM, Pyne S, et al. Sphingosine 1-phosphate and platelet-derived growth factor (PDGF) act via PDGF beta receptor-sphingosine 1-phosphate receptor complexes in airway smooth muscle cells. J Biol Chem (2003) 278:6282-90. doi:10.1074/jbc.M208560200
149. Duan RD, Nilsson A. Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development. Prog Lipid Res (2009) 48:62-72. doi:10.1016/j.plipres.2008.04.003
150. Ruckhaberle E, Rody A, Engels K, Gaetje R, Von Minckwitz G, Schiffmann S, et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat (2008) 112:41-52. doi:10.1007/s10549-007-9836-9
151. Bayerl MG, Bruggeman RD, Conroy EJ, Hengst JA, King TS, Jimenez M, et al. Sphingosine kinase 1 protein and mRNA are overexpressed in non-Hodgkin lymphomas and are attractive targets for novel pharmacological interventions. Leuk Lymphoma (2008) 49:948-54. doi:10.1080/10428190801911654
152. Kawamori T, Osta W, Johnson KR, Pettus BJ, Bielawski J, Tanaka T, et al. Sphingosine kinase 1 is up-regulated in colon carcinogenesis. FASEB J (2006) 20:386-8. doi:10.1096/fj.05-4331fje
153. Johnson KR, Johnson KY, Crellin HG, Ogretmen B, Boylan AM, Harley RA, et al. Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue. J Histochem Cytochem (2005) 53:1159-66. doi:10.1369/jhc.4A6606.2005
154. Van Brocklyn JR, Jackson CA, Pearl DK, Kotur MS, Snyder PJ, Prior TW. Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol (2005) 64:695-705. doi:10.1097/01.jnen.0000175329.59092.2c
155. French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, et al. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res (2003) 63:5962-9.
156. Ruckhaberle E, Karn T, Rody A, Hanker L, Gatje R, Metzler D, et al. Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer. J Cancer Res Clin Oncol (2009) 135:1005-13. doi:10.1007/s00432-008-0536-6
157. Sugiura M, Kono K, Liu H, Shimizugawa T, Minekura H, Spiegel S, et al. Ceramide kinase, a novel lipid kinase. Molecular cloning and functional characterization. J Biol Chem (2002) 277:23294-300. doi:10.1074/jbc.M201535200
158. Hayashi T, Su TP. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell (2007) 131:596-610. doi:10.1016/j.cell.2007.08.036
159. Lynes EM, Bui M, Yap MC, Benson MD, Schneider B, Ellgaard L, et al. Palmitoylated TMX and calnexin target to the mitochondria-associated membrane. EMBO J (2012) 31:457-70. doi:10.1038/emboj.2011.384
160. Otera H, Mihara K. Molecular mechanisms and physiologic functions of mitochondrial dynamics. J Biochem (2011) 149:241-51. doi:10.1093/jb/mvr002
161. Liesa M, Palacin M, Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev (2009) 89:799-845. doi:10.1152/physrev.00030.2008
162. Hoppins S, Lackner L, Nunnari J. The machines that divide and fuse mitochondria. Annu Rev Biochem (2007) 76:751-80. doi:10.1146/annurev.biochem.76.071905.090048
163. McBride HM, Neuspiel M, Wasiak S. Mitochondria: more than just a powerhouse. Curr Biol (2006) 16:R551-60. doi:10.1016/j.cub.2006.06.054
164. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol (2004) 287:C817-33. doi:10.1152/ajpcell.00139.2004
165. Westermann B. Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol (2010) 11:872-84. doi:10.1038/nrm3013
166. Suen DF, Norris KL, Youle RJ. Mitochondrial dynamics and apoptosis. Genes Dev (2008) 22:1577-90. doi:10.1101/gad.1658508
167. Pinton P, Giorgi C, Pandolfi PP. The role of PML in the control of apoptotic cell fate: a new key player at ER-mitochondria sites. Cell Death Differ (2011) 18:1450-6. doi:10.1038/cdd.2011.31
168. Reineke EL, Lam M, Liu Q, Liu Y, Stanya KJ, Chang KS, et al. Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells. Mol Cell Biol (2008) 28:997-1006. doi:10.1128/MCB.01848-07
169. Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ, et al. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst (2004) 96:269-79. doi:10.1093/jnci/djh043
170. Chami M, Oules B, Szabadkai G, Tacine R, Rizzuto R, Paterlini-Brechot P. Role of SERCA1 truncated isoform in the proapoptotic calcium transfer from ER to mitochondria during ER stress. Mol Cell (2008) 32:641-51. doi:10.1016/j.molcel.2008.11.014
171. Bononi A, Bonora M, Marchi S, Missiroli S, Poletti F, Giorgi C, et al. Identification of PTEN at the ER and MAMs and its regulation of Ca(2+) signaling and apoptosis in a protein phosphatase-dependent manner. Cell Death Differ (2013) 20:1631-43. doi:10.1038/cdd.2013.77
172. Schroder K, Tschopp J. The inflammasomes. Cell (2010) 140:821-32. doi:10.1016/j.cell.2010.01.040
173. Franchi L, Munoz-Planillo R, Reimer T, Eigenbrod T, Nunez G. Inflammasomes as microbial sensors. Eur J Immunol (2010) 40:611-5. doi:10.1002/eji.200940180
174. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature (2011) 469:221-5. doi:10.1038/nature09663
175. Allen IC, Tekippe EM, Woodford RM, Uronis JM, Holl EK, Rogers AB, et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med (2010) 207:1045-56. doi:10.1084/jem.20100050
176. Wei Q, Mu K, Li T, Zhang Y, Yang Z, Jia X, et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest (2014) 94:52-62. doi:10.1038/labinvest.2013.126
177. Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol (2005) 79:2689-99. doi:10.1128/JVI.79.5.2689-2699.2005
178. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol (2004) 5:730-7. doi:10.1038/ni1087
179. Matsushima-Miyagi T, Hatano K, Nomura M, Li-Wen L, Nishikawa T, Saga K, et al. TRAIL and NOXA are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles. Clin Cancer Res (2012) 18:6271-83. doi:10.1158/1078-0432.CCR-12-1595
180. Kaneda Y. The RIG-I/MAVS signaling pathway in cancer cell-selective apoptosis. Oncoimmunology (2013) 2:e23566. doi:10.4161/onci.23566
181. Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell (2010) 141:668-81. doi:10.1016/j.cell.2010.04.018
182. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell (2005) 122:669-82. doi:10.1016/j.cell.2005.08.012
183. Horner SM, Liu HM, Park HS, Briley J, Gale M Jr. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci U S A (2011) 108:14590-5. doi:10.1073/pnas.1110133108
184. Gilady SY, Bui M, Lynes EM, Benson MD, Watts R, Vance JE, et al. Ero1alpha requires oxidizing and normoxic conditions to localize to the mitochondria-associated membrane (MAM). Cell Stress Chaperones (2010) 15:619-29. doi:10.1007/s12192-010-0174-1
185. Myhill N, Lynes EM, Nanji JA, Blagoveshchenskaya AD, Fei H, Carmine Simmen K, et al. The subcellular distribution of calnexin is mediated by PACS-2. Mol Biol Cell (2008) 19:2777-88. doi:10.1091/mbc.E07-10-0995
186. Verfaillie T, Rubio N, Garg AD, Bultynck G, Rizzuto R, Decuypere JP, et al. PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell Death Differ (2012) 19:1880-91. doi:10.1038/cdd.2012.74
187. Munoz JP, Ivanova S, Sanchez-Wandelmer J, Martinez-Cristobal P, Noguera E, Sancho A, et al. Mfn2 modulates the UPR and mitochondrial function via repression of PERK. EMBO J (2013) 32:2348-61. doi:10.1038/emboj.2013.168
188. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell (2011) 147:728-41. doi:10.1016/j.cell.2011.10.026
189. Takamura A, Komatsu M, Hara T, Sakamoto A, Kishi C, Waguri S, et al. Autophagy-deficient mice develop multiple liver tumors. Genes Dev (2011) 25:795-800. doi:10.1101/gad.2016211
190. Hamasaki M, Furuta N, Matsuda A, Nezu A, Yamamoto A, Fujita N, et al. Autophagosomes form at ER-mitochondria contact sites. Nature (2013) 495:389-93. doi:10.1038/nature11910
191. Peterson TR, Laplante M, Thoreen CC, Sancak Y, Kang SA, Kuehl WM, et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell (2009) 137:873-86. doi:10.1016/j.cell.2009.03.046
192. Chen J, Long F. mTORC1 signaling controls mammalian skeletal growth through stimulation of protein synthesis. Development (2014) 141:2848-54. doi:10.1242/dev.108811
193. Masui K, Cavenee WK, Mischel PS. mTORC2 in the center of cancer metabolic reprogramming. Trends Endocrinol Metab (2014) 25:364-73. doi:10.1016/j.tem.2014.04.002
194. Betz C, Stracka D, Prescianotto-Baschong C, Frieden M, Demaurex N, Hall MN. Feature article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology. Proc Natl Acad Sci U S A (2013) 110:12526-34. doi:10.1073/pnas.1302455110